Rheumatologist (Joints & Arthritis Specialist)
The purpose of this study is to demonstrate the efficacy and safety of secukinumab 300 milligram (mg) and 150 mg administered subcutaneously (s.c.) for 52 weeks in combination with prednisone tapered over 24 weeks in adult participants with PMR who鈥�
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesJuly 19, 2017
Most people aren鈥檛 worn out by simple daily tasks requiring little exertion. But those with chronic fatigue syndrome might be exhausted by a walk across the鈥�
Division of Rheumatology and Clinical Immunology, +5 more
